Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan · Delayed Price · Currency is TWD 19.00
+0.20 (1.06%)
Oct 20, 2026, 1:58 PM CST
Anxo Pharmaceutical Market Cap
Anxo Pharmaceutical has a market cap or net worth of 1.06 billion as of October 20, 2026. It is the 33,474th most valuable company in the world and the 2,016th biggest in Taiwan. Its market cap has decreased by 26.70% in one year.
Market Cap
1.06B
Enterprise Value
1.60B
Revenue
878.88M
Global Rank
Country Rank
#2,016 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 27, 2018, Anxo Pharmaceutical's market cap has decreased from 2.16B to 1.06B, a decrease of -50.65%. That is a compound annual growth rate of -8.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.06B | 1.64% |
| Dec 31, 2025 | 1.05B | -21.58% |
| Dec 31, 2024 | 1.34B | -50.67% |
| Dec 29, 2023 | 2.71B | 89.95% |
| Dec 30, 2022 | 1.43B | 20.33% |
| Dec 30, 2021 | 1.18B | -13.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.13B |
| Tien Liang BioTech | 1.83B |
| GeneFerm Biotechnology | 1.21B |
| InnoPharmax | 1.13B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 874.13M |
| Mediera | 828.54M |